EyePoint, Inc. (EYPT)
3.32
-0.08
(-2.35%)
USD |
NASDAQ |
Oct 12, 16:00
3.315
0.00 (0.00%)
After-Hours: 20:00
EyePoint Net Income (TTM) : -306.64M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -306.64M |
| March 31, 2026 | -271.60M |
| December 31, 2025 | -231.96M |
| September 30, 2025 | -205.75M |
| June 30, 2025 | -175.38M |
| March 31, 2025 | -146.78M |
| December 31, 2024 | -130.87M |
| September 30, 2024 | -103.57M |
| June 30, 2024 | -86.82M |
| March 31, 2024 | -78.92M |
| December 31, 2023 | -70.80M |
| September 30, 2023 | -100.15M |
| June 30, 2023 | -105.96M |
| March 31, 2023 | -102.44M |
| December 31, 2022 | -102.25M |
| September 30, 2022 | -78.23M |
| June 30, 2022 | -76.51M |
| March 31, 2022 | -67.11M |
| December 31, 2021 | -58.42M |
| September 30, 2021 | -54.45M |
| June 30, 2021 | -41.56M |
| March 31, 2021 | -44.50M |
| December 31, 2020 | -45.39M |
| September 30, 2020 | -40.34M |
| June 30, 2020 | -52.18M |
| Date | Value |
|---|---|
| March 31, 2020 | -50.73M |
| December 31, 2019 | -56.79M |
| September 30, 2019 | -57.98M |
| June 30, 2019 | -75.46M |
| March 31, 2019 | -98.39M |
| December 31, 2018 | -86.13M |
| September 30, 2018 | -80.65M |
| June 30, 2018 | -52.66M |
| March 31, 2018 | -18.30M |
| June 30, 2017 | -18.48M |
| March 31, 2017 | -18.76M |
| December 31, 2016 | -18.66M |
| September 30, 2016 | -23.78M |
| June 30, 2016 | -21.55M |
| March 31, 2016 | -20.31M |
| December 31, 2015 | -20.26M |
| September 30, 2015 | -19.15M |
| June 30, 2015 | 6.347M |
| March 31, 2015 | 7.526M |
| December 31, 2014 | 10.34M |
| September 30, 2014 | 10.90M |
| June 30, 2014 | -13.36M |
| March 31, 2014 | -13.34M |
| December 31, 2013 | -13.94M |
| September 30, 2013 | -13.04M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Ocular Therapeutix, Inc. | -301.45M |
| Eli Lilly & Co. | 26.71B |
| Nuvation Bio, Inc. | -149.83M |
| ANI Pharmaceuticals, Inc. | 99.95M |
| Corcept Therapeutics, Inc. | 54.20M |